Target intelligence / Profile preview

RPS27A pseudogene 12 (RPS27AP12)

Target: RPS27AP12
Molecular classification: Other (Pseudogene; not a functional protein, enzyme, receptor, or transporter)

Overview

RPS27AP12, or ribosomal protein S27a pseudogene 12, is a processed pseudogene in the human genome[1][5]. It is derived from the parental RPS27A gene, which encodes the ribosomal protein S27a, a structural component of the 40S ribosomal subunit involved in translation and cellular stress response[3][4]. However, RPS27AP12 itself has no known protein-coding potential and does not produce functional ribosomal protein S27a. As a pseudogene, it lacks the ability to act as a functional receptor, enzyme, or therapeutic target and has no known biological functions, disease associations, or drug interactions[5].

Other names: RPS27A_5_866ribosomal protein S27a pseudogene 12RPS27AP12

Beyond the preview

Go deeper on RPS27A pseudogene 12 (RPS27AP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RPS27A pseudogene 12 (RPS27AP12).

Explore the full profile